Clinical trial
A Phase 2, Open-label, Multiple Cohort, Single-arm, Multi-center Trial to Determine the Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-cell Acute Lymphoblastic Leukemia.
NCT02973191 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Open-label, Multiple Cohort, Single-arm, Multi-center Trial to Determine the Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-cell Acute Lymphoblastic Leukemia.
- Lead sponsor
- Celgene
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- December 20, 2016
- Completion date
- January 24, 2021
- Enrollment
- 0 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.